• First Immunotherapy Approved for Breast Cancer

    Medical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.

    by Anna Azvolinsky

  • Treating Cancer Based on Its Genetics, Not Its Location

    Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.

    by Anna Azvolinsky

  • An Uncommon Partnership

    Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.

    by Ashley P. Taylor

  • The Genetics of Metastatic Cancer

    The multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.

    by Anna Azvolinsky

  • Paying for Tumor Testing

    A recent U.S. government decision about coverage of tumor sequencing could affect cancer patients.

    by Brad Jones

  • The Ins and Outs of Tumor Testing

    In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.

    by Kate Yandell

  • A New Type of Drug Approval

    At the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors' molecular characteristics, not to their tissues of origin.

    by Kate Yandell

  • A Better Way to Screen for Lynch Syndrome?

    Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.

    by Cheryl Platzman Weinstock